Heart Failure in 68 Markets – Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2032
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Heart Failure Market Report Overview
The heart failure market size across the 68M was $21.6 billion in 2022. The “Heart Failure in 68 Markets” research report covers the 68 geographical markets and provides an Excel-based forecast model for the market through 2033.
Heart Failure Market Outlook, 2022-2033 ($ Billion)
Buy the Full Report for More Insights on the Heart Failure Market Report Forecast
The Heart Failure market report contains patient-based forecast sales data for the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan) and sales forecast extrapolations for 61 additional geographical markets (61M).
| Market Size (2022) | $21.6 Billion |
| Key Regions | · Africa
· APAC · Europe · LATAM · Middle East · Others |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Heart Failure Market Segmentation by Regions
The key geographical regions encompassing the heart failure market include Africa, APAC, Europe, LATAM, the Middle East, and others. In 2022, North America accounted for the highest regional share of the heart failure market across 68M.
Heart Failure Market Analysis by Regions, 2022 (%)
Buy the Full Report for More Regional Insights on the Heart Failure Market
Download a Free Report Sample
Segments Covered in the Report
Heart Failure Market Regional Outlook (Value, $ Billion, 2022-2033)
- Africa
- APAC
- Europe
- LATAM
- Middle East
- North Aemrica
Scope
This publication is an expanded version of the Excel model containing the patient-based forecast sales for heart failure, covered in GlobalData’s report “Heart Failure: Seven -Market Drug Forecast and Market Analysis”, published in June 2024. In addition to patient-based forecast sales data for the seven major markets, this report contains sales forecast extrapolations for an additional 60 geographical markets (60M), totaling 68 markets (68M).
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the 7MM Heart Failure therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the 7MM Heart Failure therapeutics market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Bayer
Zensun
AstraZeneca
Boehringer Ingelheim
Lexicon
CSL Vifor
Eli Lilly
Novartis
Novo Nordisk
Mesoblast
BioCardia
Eris LifeSciences
Cytokinetics
Table of Contents
Frequently asked questions
-
What was the heart failure market sales across the 68M in 2022?
The heart failure market sales across the 68M was $21.6 billion in 2022.
-
Which was the leading region in the heart failure market in 2022?
In 2022, North America accounted for the highest regional share of the heart failure market across 68M.
-
Which are the key geographical regions encompassing the heart failure market?
The key geographical regions encompassing the heart failure market include Africa, APAC, Europe, LATAM, Middle East, and others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Pharmaceuticals reports

